Skip to content

Stapes Footplate Thickness Measured With UHR-CT

Stapes Footplate Thickness Measured With UHR-CT

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05799404
Enrollment
100
Registered
2023-04-05
Start date
2023-04-28
Completion date
2023-06-28
Last updated
2023-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Otitis Media, Otosclerosis

Keywords

ultra high resolution, ct, stapes, footplate, otosclerosis, otitis media

Brief summary

The aim of this study is to compare the thickness of the stapes footplate measured with ultra high resolution CT in control patients, otosclerosis patients and chronic otitis media patients.

Detailed description

Stapes footplate thickness will be measured under its anterior crus, its posterior crus and at its midpoint, in both the stapes axial plane and the laletral semi-circular canal planes.

Interventions

DIAGNOSTIC_TESTultra-high resolution CT

stapes footplate thickness measurement

Sponsors

Central Hospital, Nancy, France
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Ultra high resolution CT of the temporal bone available

Exclusion criteria

* previous surgery

Design outcomes

Primary

MeasureTime frameDescription
stapes footplate thickness in mm in the stapes axial planeoctober 2020-october 2022stapes footplate thickness measured with a digital caliper on our PACS system with the accuracy of a tenth of a millimetre, under the anterior crus of the stapes, under the posterior crus of the stapes, and at its midpoint, in the stapes axial plane and in the lateral semi circular canal plane, to compare both values and find out wich one is the most pertinent

Secondary

MeasureTime frameDescription
interobserver variabilityoctober 2020-october 2022interobserver variability

Contacts

Primary Contactromain gillet, MD
r.gillet@chru-nancy.fr003383851811

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026